E2F7, a transcription factor that regulates cell cycle and apoptosis, indirectly impacts the actions of chemotherapeutic drugs like tamoxifen, which targets cell proliferation and apoptosis pathways that E2F7 controls. While the precise pharmacokinetic interactions are not well defined, variations in the expression and function of E2F7 could influence the efficacy of tamoxifen through its effects on cell cycle regulation and cellular responses to DNA damage, thus affecting the drug's pharmacodynamic responses in tumor cells.